|
Volumn 311, Issue 1, 2001, Pages 53-56
|
C-reactive protein and cardiac troponin for early risk stratification in patients with acute coronary syndromes
|
Author keywords
Adverse outcome; Glycoprotein IIb IIIa inhibitors; Myocardial damage
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
BIOCHEMICAL MARKER;
C REACTIVE PROTEIN;
CARDIOVASCULAR AGENT;
GLYCOPROTEIN IIB INHIBITOR;
GLYCOPROTEIN IIIA INHIBITOR;
LOW MOLECULAR WEIGHT HEPARIN;
TIROFIBAN;
TROPONIN T;
UNCLASSIFIED DRUG;
CARDIOVASCULAR RISK;
CONFERENCE PAPER;
DIAGNOSTIC VALUE;
ELECTROCARDIOGRAM;
HEART INFARCTION;
HUMAN;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
SENSITIVITY AND SPECIFICITY;
ST SEGMENT;
UNSTABLE ANGINA PECTORIS;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CORONARY DISEASE;
HUMANS;
MYOCARDIUM;
RISK ASSESSMENT;
TROPONIN;
|
EID: 0035885012
PISSN: 00098981
EISSN: None
Source Type: Journal
DOI: 10.1016/S0009-8981(01)00559-9 Document Type: Conference Paper |
Times cited : (9)
|
References (29)
|